Back to 
HighTower Advisors, LLC
HighTower Advisors, LLCCOCODX
Showing 0 of 16 quarters
Position history for HighTower Advisors, LLC's holdings in Co-Diagnostics, Inc.
No. HighTower Advisors exited its CODX (Co-Diagnostics) position in Q3 2022. Its Q2 2022 13F listed 45,830 shares worth $256,000. HighTower Advisors already held CODX in its Q4 2018 13F, the earliest on record, and held it in 15 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.